Terms ending in 2034
Every in-force patent on Ipierian, Inc.'s record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,980,270 | Methods of Treating a Tauopathy In force · Medium confidence | Ipierian, Inc. | In force | Medium confidence | |
| US 8,980,271 | Methods of Treating a Tauopathy In force · Medium confidence | Ipierian, Inc. | In force | Medium confidence | |
| US 9,051,367 | Methods of Treating a Tauopathy In force · Medium confidence | Ipierian, Inc. | In force | Medium confidence | |
| US 9,447,180 | Methods of Treating a Tauopathy In force · Medium confidence | Ipierian, Inc. | In force | Medium confidence | |
| US 9,777,058 | Methods of Treating a Tauopathy In force · Medium confidence | Ipierian, Inc. | In force | Medium confidence | |
| US 10,400,018 | Tau Peptides, Anti-Tau Antibodies, and Methods of Use Thereof In force · High confidence | Ipierian, Inc. | In force | High confidence |
6 of 6 patents shown. Soonest term end first, then patent number.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.